Aeglea BioTherapeutics, Inc. (AGLE) has a market capitalization of $48.63M and trades at $12.01. The 52-week range is 2.66-24.0.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.1, Earnings Per Share (EPS) of $-1.98.
The stock has a beta of 2.57, operates in the Healthcare sector.
